ArticleFrontiers in immunology2025
A novel multi-layered immune structural model for peripheral blood immune scoring in cancer patients: perspective and hypothesis.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From peripheral blood to tumor microenvironment: spatial dimension deficiency and paradigm reconstruction in immunotherapy biomarker research.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurately assessing and quantifying immune competence in cancer patients remains a major challenge in tumor immunology. Traditional intratumoral immune profiling, such as tissue pathology and tissue-based cytometry techniques, faces significant challenges due to difficulties in tissue sampling, spatial heterogeneity, and technical limitations. In contrast, peripheral blood immune profiling is a more practical and reproducible approach, providing valuable insights into systemic immune status. This article introduces a novel immune structural model, inspired by protein structural hierarchy, to classify immune components into three hierarchical levels: primary, secondary, and tertiary immune structures. We hypothesize that this model can provide a systematic framework for constructing an immune scoring system (ISS) that integrates multi-dimensional immune information from flow cytometry, cytokine profiling, and immune checkpoint molecule assessments. The proposed model offers a new way to assess immune status and could serve as a valuable tool for clinical personalized treatment and prognostic evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.